Synthesis and in vitro study of novel Bis-[3-(2- Arylmethylidenimino-1,3- thiazol-4-yl)-4-hydroxy-2H-chromen-2- one-6-yl]methane and Bis-[3-(2- arylidenhydrazo-1,3-thiazol-4-yl)- 4-hydroxy-2H-chromen-2-one-6-yl]methane as potential antimicrobial agents

Journal of Heterocyclic Chemistry

Volumn 46, Issue 2, 2009, Pages 261-267

  Raghu, M ^a   Nagaraj, A ^a   Reddy, Ch Sanjeeva ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BIS[3 (2 ARYLIDENHYDRAZO 1,3 THIAZOL 4 YL) 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 (2 ARYLMETHYLIDENIMINO 1,3 THIAZOL 4 YL) 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 (2 PHENYLIDENHYDRAZO 1,3 THIAZOL 4 YL) 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 (2 PHENYLMETHYLIDENIMINO 1,3 THIAZOL 4 YL) 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (2 FURYL)METHYLIDENIMINO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (2 FURYLIDEN)HYDRAZO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (3,4 METHYLENDIOXYPHENYLIDEN)HYDRAZO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (4 BROMOPHENYLIDEN)HYDRAZO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (4 METHOXYPHENYLIDEN)HYDRAZO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (4 NITROPHENYL)METHYLIDENIMINO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; BIS[3 [2 (4 NITROPHENYLIDEN)HYDRAZO 1,3 THIAZOL 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE 6 YL]METHANE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; CANDIDA ALBICANS; CHEMICAL ANALYSIS; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; PROTEUS VULGARIS; PROTON NUCLEAR MAGNETIC RESONANCE; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

EID: 65349183985     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.63     Document Type: Article

References (25)

1. De Logu, A.; Saddi, M.; Cardia, M. C.; Borgna, R.; Sanna, C.; Saddi, B.; Maccioni, E. J Antimicrob Chemother 2005, 55, 692.
2. Onyewu, C.; Blankenship, J. R.; Del Poeta, M.; Heitman, J. Antimicrob Agents Chemother 2003, 47, 956.
3. Storer, R.; Ashton, C. J.; Baxter, A. D.; Hann, M. M.; Marr, C. L.; Mason, A. M.; Mo, C. L.; Myers, P. L.; Noble, S. A.; Penn, C. R.; Weir, N. G.; Woods, J. M.; Coe, P. L. Nucleosides Nucleotides 1999, 18, 203.
4. James, M. N. G.; Watson, K. J. J Chem Soc C 1966, 1361.
5. Ghazzi, M. N.; Perez, J. E.; Antonucci, T. K.; Driscoll, J. H.; Huang, S. M.; Faja, B. W. Diabetes 1997, 46, 433.
6. Schmidt, U.; Utz, R.; Lieberknecht, A.; Griesser, H.; Pot - zolli, B.; Bahr-Thielemann, J.; Wagner, K.; Fischer, P. Synthesis 1987, 20, 233.
7. (a) Geen, G. R.; Evans, J. M.; Vong, A. K. In Comprehensive Heterocyclic Chemistry II: Pyrans and their Benzo Derivatives: Applications; Katritzky, A. R., Rees, C. W., Scriven E. F. V.; Perga- mon Press: Oxford, 1996; Vol. 5, p 469.
8. (b) Billeret, D.; Blondeau, D.; Sliwa, H. J. Heterocyclic. Chem.1993, 30, 671.
9. Vallet, F. M. J Ger Offen 1978, 2, 751.
10. Suzmann, M. M. IV World Congress of Cardiology; Mexico, 1962, p 344.
11. Doucet, C.; Pochet, L.; Thierry, N.; Pirotte, B.; Delarge, J.; Reboud-Ravaux, M. J Med Chem 1999, 42, 4161.
12. Pochet, L.; Doucet, C.; Schynts, M.; Therry, N.; Boggetto, N.; Pirotte, B.; Jiang, K. Y.; Masereel.B.; de Tullio, P.; Delarge, J.; Reboud-Ravaux, M. J Med Chem 1996, 39, 2579.
13. Spiro, V.; Madonia, P. Atti Acad Sci Lett Antipalermo 1959, A95920187.
14. (a) Mitra, A. K.; De, A.; Karchaudhuri, N.; Misra, S. K.; Mukhopadhyay, A. K. J Indian Chem Soc 1998, 75, 666.
15. (b) Cravotto, G.; Nano, G. M.; Palmisano, G.; Tagliapietra, S. Tetrahedron Asymmetry 2001, 12, 707.
16. Wang, C. J.; Hsieh, Y. J.; Chu, C. Y.; Lin, Y. L.; Tseng, T. H. Cancer Lett 2002, 183, 163.
17. Kirkiacharian, S.; Thuy, D. T.; Sicsis, S.; Bakhchinian, R.; Kurkjian, R.; Tonnaire, T. Il Farmaco 2002, 57, 703.
18. Kayser, O.; Kolodziej, H. Planta Med 1997, 63, 508.
19. (a) Sanjeeva Reddy, C;,Nagaraj, A. J. Heterocyclic Chem 2007, 44, 1181.
20. (b) Sanjeeva Reddy, C.; Ngaraj, A. J. Heterocyclic Chem 2007, 44, 1357.
21. (c) Srinivas, A.; Nagaraj, A.; Sanjeeva Reddy, C. J Heterocyclic Chem 2008, 45, 999.
22. (d) Raghu, M.; Nagaraj, A.; Sanjeeva Reddy, C. J Heterocyclic Chem 2008, 45, 1115.
23. (e) Srinivas, A.; Nagaraj, A.; Sanjeeva Reddy, C. J Heterocyclic Chem 2008, 45, 1121.
24. Clemmensen, E.; Heitman, A. H. C. J Am Chem Soc 1911, 33, 733.
25. National Committee for Clinical Laboratory Standards (NCCLS). Nat Comm Lab Stands Villanova 1982, 242.